Patents by Inventor Won-Kyung Cho

Won-Kyung Cho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210315957
    Abstract: A pharmaceutical composition and a health functional food composition for preventing, treating, or improving muscular diseases have licorice extract or a fraction thereof, or a compound isolated therefrom or a pharmaceutically acceptable salt thereof, as an active ingredient. The licorice extract or a fraction thereof, the compound or salt thereof induce the myoblasts proliferation and promote the differentiation into myotubes, and since the licorice extract or a fraction thereof, the compound or salt thereof has an excellent effect on regenerating damaged muscles, various muscle diseases are effectively prevented, improved or treated using the composition.
    Type: Application
    Filed: June 17, 2020
    Publication date: October 14, 2021
    Applicants: RESEARCH COOPERATION FOUNDATION OF YEUNGNAM UNIVERSITY, KOREA INSTITUTE OF ORIENTAL MEDICINE, DAEGU CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
    Inventors: Inho CHOI, Eun Ju LEE, So-young PARK, Yong-Ho LEE, Jin Yeul MA, Won-Kyung CHO, Hye Jin YANG
  • Publication number: 20200215040
    Abstract: One aspect of the present disclosure is a pharmaceutical composition which includes (R)—N-[1-(3,5-difluoro-4-methansulfonylamino-phenyl)-ethyl]-3-(2-propyl-6-trifluoromethyl-pyridin-3-yl)-acrylamide as a first component and a cellulosic polymer as a second component, wherein the composition of one aspect of the present disclosure has a formulation characteristic in which crystal formation is delayed for a long time.
    Type: Application
    Filed: August 10, 2018
    Publication date: July 9, 2020
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Joon Ho CHOI, Won Kyung CHO, Kwang-Hyun SHIN, Byoung Young WOO, Ki-Wha LEE, Min-Soo KIM, Jong Hwa ROH, Mi Young PARK, Young-Ho PARK, Eun Sil PARK, Jae Hong PARK
  • Publication number: 20190328808
    Abstract: The present invention relates to a pharmaceutical composition comprising a maple leaf extract or fraction thereof for preventing or treating a retinal disease, a method for preventing or treating a retinal disease using the pharmaceutical composition, and a food composition comprising a maple leaf extract or fraction thereof for ameliorating the symptoms of a retinal disease. The pharmaceutical composition according to the present invention, which is effective for the treatment of a retinal disease, can be used pharmaceutically as a composition for preventing or treating a retinal disease, and can also be used advantageously as a health functional food.
    Type: Application
    Filed: August 11, 2017
    Publication date: October 31, 2019
    Inventors: Jin Yeul MA, Kwang Il PARK, Yeoun-Hee KIM, Tae Woo OH, Won Kyung CHO, Dong-Gun KIM, Eun Hee PARK
  • Patent number: 10357528
    Abstract: The present invention relates to a pharmaceutical composition for preventing and treating corneal diseases or conjunctival diseases, containing a maple leaf extract as an active ingredient. The maple leaf extract exhibits an effect of inhibiting hyperemia in the eyeball in which hyperemia has been induced and an effect of inhibiting angiogenesis in the eyeball in which corneal damage has been induced, thus being effectively used in a pharmaceutical composition for preventing and treating corneal diseases or conjunctival diseases.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: July 23, 2019
    Assignee: KOREA INSTITUTE OF ORIENTAL MEDICINE
    Inventors: Jin Yeul Ma, Jung Hyun Kim, Jong Wook Jeon, You Chang Oh, Won Kyung Cho, Youn Hwan Hwang, Nam Hui Yim, Jae Myung Yoo
  • Publication number: 20180264064
    Abstract: The present invention relates to a pharmaceutical composition for preventing and treating corneal diseases or conjunctival diseases, containing a maple leaf extract as an active ingredient. The maple leaf extract exhibits an effect of inhibiting hyperemia in the eyeball in which hyperemia has been induced and an effect of inhibiting angiogenesis in the eyeball in which corneal damage has been induced, thus being effectively used in a pharmaceutical composition for preventing and treating corneal diseases or conjunctival diseases.
    Type: Application
    Filed: July 8, 2016
    Publication date: September 20, 2018
    Inventors: Jin Yeul MA, Jung Hyun KIM, Jong Wook JEON, You Chang OH, Won Kyung CHO, Youn Hwan HWANG, Nam Hui YIM, Jae Myung YOO
  • Patent number: 8734830
    Abstract: The present invention relates to a novel technology for forming fine particles with a size of 0.0˜23 microns from a solid that can be dissolved in a liquid solvent and is not decomposed by heat. The particle preparation technology according to the present invention may be applicable to the fields of food, cosmetics, biopolymer, polymer compositions, and pharmaceuticals.
    Type: Grant
    Filed: March 3, 2010
    Date of Patent: May 27, 2014
    Assignee: Korea United Pharm. Inc.
    Inventors: Sung Joo Hwang, Min Soo Kim, Jeong Soo Kim, Kwang Ho Cha, Won Kyung Cho, Jun Sung Park, Suk Jun Seo
  • Publication number: 20110200678
    Abstract: The present invention relates to a novel technology for forming fine particles with a size of 0.02˜3 microns from a solid that can be dissolved in a liquid solvent and is not decomposed by heat. The particle preparation technology according to the present invention may be applicable to the fields of food, cosmetics, biopolymer, polymer compositions, and pharmaceuticals.
    Type: Application
    Filed: March 3, 2010
    Publication date: August 18, 2011
    Applicant: THE INDUSTRY METHOD AND APPARATUS OF ULTRAFINE PARTICLES HAVING UNIFORM PARTICLE SIZE DISTRIBUTIO
    Inventors: Sung Joo Hwang, Min Soo Kim, Jeong Soo Kim, Kwang Ho Cha, Won Kyung Cho, Jun Sung Park, Suk Jun Seo
  • Patent number: 6800479
    Abstract: The present invention relates to recombinant adenoviruses expressing interleukin-18 protein, and gene therapy using them. More particularly, the invention provides recombinant adenoviruses Ad.promIL-18, Ad.GMmIL-18, Ad.prohIL-18, Ad.hIL-18CPP32- and Ad.preprotrypsin.hIL-18CPP32- which are effectively capable of treating a variety of cancer cells by promoting and enhancing an immune response in vivo.
    Type: Grant
    Filed: March 22, 2002
    Date of Patent: October 5, 2004
    Assignees: Samyang Genex Corporation, Korea Research Institute of Bioscience & Biotechnology
    Inventors: Dong-Soo Im, Won-Kyung Cho, Kyung-Sun Hwang
  • Publication number: 20030143203
    Abstract: The present invention relates to recombinant adenoviruses expressing interleukin-18 protein, and gene therapy using them. More particularly, the invention provides recombinant adenoviruses Ad.promIL-18, Ad.GMmIL-18, Ad.prohIL-18, Ad.hIL-18CPP32- and Ad.preprotrypsin.hIL-18CPP32- which are effectively capable of treating a variety of cancer cells by promoting and enhancing an immune response in vivo.
    Type: Application
    Filed: March 22, 2002
    Publication date: July 31, 2003
    Inventors: Dong-Soo Im, Won-Kyung Cho, Kyung-Sun Hwang, Young-Rim Seong, Seung-Suh Hong
  • Publication number: 20020165190
    Abstract: The present invention relates to a vector comprising P972 (also referred to as Gadd45&ggr;, CR6 or OIG37) gene known as a gene producing a cell growth-inhibiting protein for the treatment of cancers, an recombinant adenovirus that encodes P972 gene in the cell, a method of producing the above adenovirus and a method for the treatment of cancers by using the above vector or adenovirus. The recombinant adenovirus of the present invention can be used in the treatment of various cancers including cervical cancer, breast cancerand colon cancer.
    Type: Application
    Filed: May 3, 2002
    Publication date: November 7, 2002
    Inventors: Kim Dae Gun, Won-Kyung Cho, Neon-Cheol Jung, Young-Rim Seong, Dong-Soo Im, Seung-Suh Hong, Hyun-Soo Lee